La gestione del paziente HBsAg positivo, HCV positivo e HIV positivo in dialisi

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney Disease

  2012cited by this paper
• Seropositivity for Anti-HCV Core Antigen is Independently Associated With Increased All-Cause, Cardiovascular, and Liver Disease-Related Mortality in Hemodialysis Patients

  2011cited by this paper
• Combined antiviral therapy of hepatitis C virus in dialysis patients: meta‐analysis of clinical trials

  2011cited by this paper
• Boceprevir for untreated chronic HCV genotype 1 infection.

  2011cited by this paper
• Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand

  2010cited by this paper
• Telaprevir for previously treated chronic HCV infection.

  2010cited by this paper
• Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy

  2009cited by this paper
• HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin

  2009cited by this paper
• Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.

  2009cited by this paper
• Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose Ribavirin

  2008cited by this paper
• Hepatitis B and Hepatitis C Virus Infection and Outcome of Hemodialysis and Kidney Transplant Patients

  2008cited by this paper
• The impact of hepatitis C virus infection on survival in dialysis patients: meta‐analysis of observational studies

  2007cited by this paper
• The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant.

  2007cited by this paper
• Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.

  2007cited by this paper
• Prophylaxis and treatment of hepatitis B in immunocompromised patients.

  2007cited by this paper
• Hepatitis C virus and death risk in hemodialysis patients.

  2006cited by this paper
• Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients

  2006cited by this paper
• Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

  2005cited by this paper
• Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2002

  2005cited by this paper
• Patient-to-patient transmission of hepatitis C.

  2005cited by this paper
• Excellent Outcome of Lamivudine Treatment in Patients With Chronic Renal Failure and Hepatitis B Virus Infection

  2003cited by this paper
• Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

  2003cited by this paper
• Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

  2003cited by this paper
• Lamivudine in renal transplant candidates with chronic hepatitis B infection.

  2002cited by this paper
• Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis.

  2001cited by this paper
• HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.

  2000cited by this paper
• An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation

  2000cited by this paper
• Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.

  1998cited by this paper
• Prevention of hepatitis C virus in dialysis units.

  1995cited by this paper
• Prevention of hepatitis C infection in haemodialysis units. A prospective study.

  1995cited by this paper
• Transmission of HIV in dialysis centre.

  1995cited by this paper

• No citing papers are available for this paper.